Dacomitinib free base ≥99% (by HPLC)

Supplier: Enzo Life Sciences

Synonyms: (E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]-4-(piperidin-1-yl)but-2-enamide, (E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide, PF 00299804

CHM221-0025 CHM221-0050 CHM221-0100 CHM221-0200 CHM221-0250 CHM221-0500
76203-182EA 392.4 USD
76203-182 76203-184 76203-186 76203-188 76203-190 76203-192
Dacomitinib free base ≥99% (by HPLC)
Dacomitinib

Dacomitinib is a potent, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity.


  • Potent inhibitor of the EGFR family of tyrosine kinases


White solid.


Soluble in DMSO.

Formula: C₂₄H₂₅ClFN₅O₂
MW: 469.95 g/mol
Storage Temperature: Freezer
MDL Number: MFCD19443734
CAS Number: 1110813-31-4
https://digitalassets.avantorsciences.com/adaptivemedia/rendition?id=9e7351b6f6553f020e27f063d6abe8d4d5fda8fa&vid=a8301e015b457fce1b9b22efd059a3efcc934464&prid=web&clid=SAPDAM

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR